Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours
- 1 February 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (2), 177-184
- https://doi.org/10.1016/0277-5379(89)90005-9
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Prognosis Following Chemotherapy for Metastatic Malignant TeratomaBritish Journal of Urology, 1987
- Proliferation of human testicular tumoursInternational Journal of Andrology, 1987
- Have new aggressive chemotherapy regimens improved results in advanced germ cell tumors?European Journal of Cancer and Clinical Oncology, 1986
- High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumorsEuropean Journal of Cancer and Clinical Oncology, 1986
- Cis-diammine-1, 1-cyclobutane dicarboxylate platinum II (carboplatin) in the treatment of testicular germ-cell tumours: a preliminary reportCancer Treatment Reviews, 1985
- FURTHER ADVANCES IN THE MANAGEMENT OF MALIGNANT TERATOMAS OF THE TESTIS AND OTHER SITESThe Lancet, 1983
- L.H. Gray medal lecture: Cell kinetics and radiation oncologyInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Relationship between the growth rate of human metastases, survival and pathological typeEuropean Journal of Cancer (1965), 1974